A citation-based method for searching scientific literature

Matthias Van Haele, Sara Vander Borght, An Ceulemans, Michiel Wieërs, Sofie Metsu, Xavier Sagaert, Birgit Weynand. J Clin Pathol 2020
Times Cited: 22







List of co-cited articles
114 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer.
Solène M Evrard, Estelle Taranchon-Clermont, Isabelle Rouquette, Samuel Murray, Sebastian Dintner, Yun-Chung Nam-Apostolopoulos, Beatriz Bellosillo, Mar Varela-Rodriguez, Ernest Nadal, Klaus H Wiedorn,[...]. J Mol Diagn 2019
26
54

Evaluation of a fast and fully automated platform to diagnose EGFR and KRAS mutations in formalin-fixed and paraffin-embedded non-small cell lung cancer samples in less than one day.
Laetitia Lambros, Charline Caumont, Briac Guibourg, Fanny Barel, Isabelle Quintin-Roué, Pascale Marcorelles, Jean-Philippe Merlio, Arnaud Uguen. J Clin Pathol 2017
32
45

Evaluation, Validation, and Implementation of the Idylla System as Rapid Molecular Testing for Precision Medicine.
Huiya Huang, Stephanie Springborn, Kiefer Haug, Kaitlyn Bartow, Hasan Samra, Smitha Menon, Alexander C Mackinnon. J Mol Diagn 2019
19
52

EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay.
Caterina De Luca, Gianluca Gragnano, Pasquale Pisapia, Elena Vigliar, Umberto Malapelle, Claudio Bellevicine, Giancarlo Troncone. J Clin Pathol 2017
38
40

Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm.
Caterina De Luca, Alessandra G Rappa, Gianluca Gragnano, Umberto Malapelle, Giancarlo Troncone, Massimo Barberis. J Clin Pathol 2018
25
31

Evaluation of the Idylla system to detect the EGFRT790M mutation using extracted DNA.
Claire Bocciarelli, Justine Cohen, Romain Pelletier, Jeanne Tran Van Nhieu, Jonathan Derman, Loetitia Favre, Anaïs Bourgogne, Isabelle Monnet, Christos Chouaid, Anaïs Pujals. Pathol Res Pract 2020
13
53

Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer.
Mercedes Delgado-García, Birgit Weynand, Lourdes Gómez-Izquierdo, María José Hernández, Ángela María Blanco, Mar Varela, Xavier Matias-Guiu, Ernest Nadal, Bélgica Márquez-Lobo, Ana Alarcão,[...]. BMC Cancer 2020
8
75



Reduced sensitivity for EGFR T790M mutations using the Idylla EGFR Mutation Test.
Eric Lee, Victoria Jones, Eleni Topkas, James Harraway. J Clin Pathol 2021
13
38

Multi-center evaluation of the novel fully-automated PCR-based Idylla™ BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanoma.
Linea Melchior, Morten Grauslund, Beatriz Bellosillo, Clara Montagut, Erica Torres, Ester Moragón, Isabel Micalessi, Johan Frans, Veerle Noten, Claire Bourgain,[...]. Exp Mol Pathol 2015
35
22

Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform.
Cornelis Bisschop, Arja Ter Elst, Lisette J Bosman, Inge Platteel, Mathilde Jalving, Anke van den Berg, Arjan Diepstra, Bettien van Hemel, Gilles F H Diercks, Geke A P Hospers,[...]. Melanoma Res 2018
31
18

Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer.
Marius Ilie, Catherine Butori, Sandra Lassalle, Simon Heeke, Nicolas Piton, Jean-Christophe Sabourin, Virginie Tanga, Kevin Washetine, Elodie Long-Mira, Priscilla Maitre,[...]. Oncotarget 2017
37
18

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
D Planchard, S Popat, K Kerr, S Novello, E F Smit, C Faivre-Finn, T S Mok, M Reck, P E Van Schil, M D Hellmann,[...]. Ann Oncol 2018
704
18

Fully automated real-time PCR for EGFR testing in non-small cell lung carcinoma.
Richard Colling, Hollie Bancroft, Gerald Langman, Elizabeth Soilleux. Virchows Arch 2019
19
21

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
Jean-Charles Soria, Yuichiro Ohe, Johan Vansteenkiste, Thanyanan Reungwetwattana, Busyamas Chewaskulyong, Ki Hyeong Lee, Arunee Dechaphunkul, Fumio Imamura, Naoyuki Nogami, Takayasu Kurata,[...]. N Engl J Med 2018
18

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
D Planchard, S Popat, K Kerr, S Novello, E F Smit, C Faivre-Finn, T S Mok, M Reck, P E Van Schil, M D Hellmann,[...]. Ann Oncol 2018
636
18

Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis.
Caterina De Luca, Roberta Sgariglia, Mariantonia Nacchio, Pasquale Pisapia, Ilaria Migliatico, Eduardo Clery, Gianluca Gragnano, Severo Campione, Elena Vigliar, Umberto Malapelle,[...]. Diagn Cytopathol 2020
11
36

Rapid detection of EGFR mutations in decalcified lung cancer bone metastasis.
Antoine Boureille, Carole Ferraro-Peyret, Guillaume Pontarollo, Cyrille Confavreux, Jean-Baptiste Pialat, Sylvie Isaac, Fabien Forest, Violaine Yvorel, Emmanuel Watkin, Nicolas Girard,[...]. J Bone Oncol 2020
7
57

Rapid EGFR mutation testing in lung cancer tissue samples using a fully automated system and single-use cartridge.
M Rabie Al-Turkmani, Michael A Suriawinata, Sophie J Deharvengt, Donald C Green, Candice C Black, Keisuke Shirai, Konstantin H Dragnev, Gregory J Tsongalis. Pract Lab Med 2020
6
66

Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France).
Sandra Lassalle, Véronique Hofman, Simon Heeke, Jonathan Benzaquen, Elodie Long, Michel Poudenx, Elisabeth Lantéri, Jacques Boutros, Virginie Tanga, Katia Zahaf,[...]. Cancers (Basel) 2020
12
33

Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study.
Caterina De Luca, Floriana Conticelli, Alvaro Leone, Gianluca Gragnano, Maria Salatiello, Pasqualina Galasso, Pasquale Pisapia, Lucia Rosalba Grillo, Antonino Iaccarino, Elena Vigliar,[...]. J Clin Pathol 2019
13
30

Ultrarapid EGFR Mutation Screening Followed by Comprehensive Next-Generation Sequencing: A Feasible, Informative Approach for Lung Carcinoma Cytology Specimens With a High Success Rate.
Maria E Arcila, Soo-Ryum Yang, Amir Momeni, Douglas A Mata, Paulo Salazar, Roger Chan, Daniela Elezovic, Ryma Benayed, Ahmet Zehir, Darren J Buonocore,[...]. JTO Clin Res Rep 2020
11
36

Rapid EGFR Mutation Detection Using the Idylla Platform: Single-Institution Experience of 1200 Cases Analyzed by an In-House Developed Pipeline and Comparison with Concurrent Next-Generation Sequencing Results.
Amir Momeni-Boroujeni, Paulo Salazar, Tao Zheng, Nana Mensah, Ivelise Rijo, Snjezana Dogan, JinYuan Yao, Christine Moung, Chad Vanderbilt, Jamal Benhamida,[...]. J Mol Diagn 2021
9
44




The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis.
Yue-Lun Zhang, Jin-Qiu Yuan, Kai-Feng Wang, Xiao-Hong Fu, Xiao-Ran Han, Diane Threapleton, Zu-Yao Yang, Chen Mao, Jin-Ling Tang. Oncotarget 2016
286
13


EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathology.
Vincent Thomas De Montpréville, Maria-Rosa Ghigna, Ludovic Lacroix, Antoinette Lemoine, Benjamin Besse, Olaf Mercier, Élie Fadel, Peter Dorfmuller, Thierry Le Chevalier. Pathol Res Pract 2017
14
21

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.
Tony S Mok, Yi-Long Wu, Sumitra Thongprasert, Chih-Hsin Yang, Da-Tong Chu, Nagahiro Saijo, Patrapim Sunpaweravong, Baohui Han, Benjamin Margono, Yukito Ichinose,[...]. N Engl J Med 2009
13

Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer.
Iván Prieto-Potin, Clara Montagut, Beatriz Bellosillo, Matthew Evans, Matthew Smith, Linea Melchior, Werner Reiltin, Michael Bennett, Veronica Pennati, Francesca Castiglione,[...]. J Mol Diagn 2018
19
15

Mutations of the BRAF gene in human cancer.
Helen Davies, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J Garnett, William Bottomley,[...]. Nature 2002
13

Rapid BRAF Mutation Testing in Pigmented Melanomas.
Danielle R Petty, Omer A Hassan, Callie S Barker, Stacey S O'Neill. Am J Dermatopathol 2020
5
60

Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples.
Francesco Pepe, Caterina De Luca, Riccardo Smeraglio, Pasquale Pisapia, Roberta Sgariglia, Mariantonia Nacchio, Maria Russo, Nicola Serra, Danilo Rocco, Ciro Battiloro,[...]. J Clin Pathol 2019
27
13

Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.
Umberto Malapelle, Clara Mayo de-Las-Casas, Danilo Rocco, Monica Garzon, Pasquale Pisapia, Nuria Jordana-Ariza, Maria Russo, Roberta Sgariglia, Caterina De Luca, Francesco Pepe,[...]. Br J Cancer 2017
89
13

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.
Neal I Lindeman, Philip T Cagle, Mary Beth Beasley, Dhananjay Arun Chitale, Sanja Dacic, Giuseppe Giaccone, Robert Brian Jenkins, David J Kwiatkowski, Juan-Sebastian Saldivar, Jeremy Squire,[...]. J Mol Diagn 2013
345
13

Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers.
Snjezana Dogan, Ronglai Shen, Daphne C Ang, Melissa L Johnson, Sandra P D'Angelo, Paul K Paik, Edyta B Brzostowski, Gregory J Riely, Mark G Kris, Maureen F Zakowski,[...]. Clin Cancer Res 2012
372
13

Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies.
Emmet J Jordan, Hyunjae R Kim, Maria E Arcila, David Barron, Debyani Chakravarty, JianJiong Gao, Matthew T Chang, Andy Ni, Ritika Kundra, Philip Jonsson,[...]. Cancer Discov 2017
334
13

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.
Ahmet Zehir, Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R Kim, Preethi Srinivasan, Jianjiong Gao, Debyani Chakravarty, Sean M Devlin,[...]. Nat Med 2017
13

Optimizing Workflows and Processing of Cytologic Samples for Comprehensive Analysis by Next-Generation Sequencing: Memorial Sloan Kettering Cancer Center Experience.
Shaozhou Ken Tian, J Keith Killian, Natasha Rekhtman, Ryma Benayed, Sumit Middha, Marc Ladanyi, Oscar Lin, Maria E Arcila. Arch Pathol Lab Med 2016
56
13

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.
Donavan T Cheng, Talia N Mitchell, Ahmet Zehir, Ronak H Shah, Ryma Benayed, Aijazuddin Syed, Raghu Chandramohan, Zhen Yu Liu, Helen H Won, Sasinya N Scott,[...]. J Mol Diagn 2015
13

[EGFR molecular characterization in non-small cell bronchic cancer: comparative prospective study by NGS and Idylla platform technologies].
Louise-Marie Chevalier, Amandine Billaud, Christophe Passot, Adélaïde Renoult, Frédéric Bigot, Véronique Verrièle, Alain Morel. Ann Pathol 2020
7
42


Detection of rare and novel EGFR mutations in NSCLC patients: Implications for treatment-decision.
A C Sousa, C Silveira, A Janeiro, S Malveiro, A R Oliveira, M Felizardo, F Nogueira, E Teixeira, J Martins, M Carmo-Fonseca. Lung Cancer 2020
21
14

KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors.
David S Hong, Marwan G Fakih, John H Strickler, Jayesh Desai, Gregory A Durm, Geoffrey I Shapiro, Gerald S Falchook, Timothy J Price, Adrian Sacher, Crystal S Denlinger,[...]. N Engl J Med 2020
531
13

Financial implications of Idylla testing in colorectal cancer, lung cancer and melanoma: a French laboratory point of view.
Glen Le Flahec, Briac Guibourg, Pascale Marcorelles, Arnaud Uguen. J Clin Pathol 2017
8
37

Comparison of Tissue Molecular Biomarker Testing Turnaround Times and Concordance Between Standard of Care and the Biocartis Idylla Platform in Patients With Colorectal Cancer.
Gregory J Tsongalis, M Rabie Al Turkmani, Michael Suriawinata, Michael J Babcock, Kristi Mitchell, Yi Ding, Lisa Scicchitano, Adrian Tira, Lela Buckingham, Sara Atkinson,[...]. Am J Clin Pathol 2020
6
50


Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
Tindaro Giardina, Cleo Robinson, Fabienne Grieu-Iacopetta, Michael Millward, Barry Iacopetta, Dominic Spagnolo, Benhur Amanuel. Pathology 2018
23
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.